Docality.com Logo
 
Dr. Rakesh  Mittal  Md,Phd image

Dr. Rakesh Mittal Md,Phd

5880 49Th St N Suite N105
St Petersburg FL 33709
727 270-0797
Medical School: Other - 1986
Accepts Medicare: Yes
Participates In eRX: Yes
Participates In PQRS: No
Participates In EHR: No
License #: ME0073653
NPI: 1023046562
Taxonomy Codes:
207R00000X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Dr. Rakesh Mittal is associated with these group practices

Procedure Pricing

HCPCS Code Description Average Price Average Price
Allowed By Medicare
HCPCS Code:99306 Description:Nursing facility care init Average Price:$300.00 Average Price Allowed
By Medicare:
$163.76
HCPCS Code:G0438 Description:PPPS, initial visit Average Price:$300.00 Average Price Allowed
By Medicare:
$166.15
HCPCS Code:99239 Description:Hospital discharge day Average Price:$230.00 Average Price Allowed
By Medicare:
$104.09
HCPCS Code:99220 Description:Initial observation care Average Price:$290.00 Average Price Allowed
By Medicare:
$180.98
HCPCS Code:99232 Description:Subsequent hospital care Average Price:$170.00 Average Price Allowed
By Medicare:
$70.65
HCPCS Code:99233 Description:Subsequent hospital care Average Price:$200.00 Average Price Allowed
By Medicare:
$101.44
HCPCS Code:99309 Description:Nursing fac care subseq Average Price:$180.00 Average Price Allowed
By Medicare:
$87.30
HCPCS Code:99217 Description:Observation care discharge Average Price:$160.00 Average Price Allowed
By Medicare:
$70.86
HCPCS Code:99223 Description:Initial hospital care Average Price:$280.00 Average Price Allowed
By Medicare:
$199.10
HCPCS Code:99316 Description:Nursing fac discharge day Average Price:$160.00 Average Price Allowed
By Medicare:
$100.93
HCPCS Code:99308 Description:Nursing fac care subseq Average Price:$125.00 Average Price Allowed
By Medicare:
$66.58
HCPCS Code:99214 Description:Office/outpatient visit est Average Price:$150.00 Average Price Allowed
By Medicare:
$104.45
HCPCS Code:90656 Description:Flu vaccine no preserv 3 & > Average Price:$35.00 Average Price Allowed
By Medicare:
$12.40
HCPCS Code:99205 Description:Office/outpatient visit new Average Price:$220.00 Average Price Allowed
By Medicare:
$201.91
HCPCS Code:99212 Description:Office/outpatient visit est Average Price:$55.00 Average Price Allowed
By Medicare:
$42.50
HCPCS Code:99213 Description:Office/outpatient visit est Average Price:$80.00 Average Price Allowed
By Medicare:
$70.65
HCPCS Code:J3420 Description:Vitamin b12 injection Average Price:$5.00 Average Price Allowed
By Medicare:
$0.53
HCPCS Code:G0008 Description:Admin influenza virus vac Average Price:$5.00 Average Price Allowed
By Medicare:
$5.00

HCPCS Code Definitions

99205
Office or other outpatient visit for the evaluation and management of a new patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 60 minutes are spent face-to-face with the patient and/or family.
99212
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A problem focused history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self limited or minor. Typically, 10 minutes are spent face-to-face with the patient and/or family.
99213
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.
99214
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.
99217
Observation care discharge day management (This code is to be utilized to report all services provided to a patient on discharge from "observation status" if the discharge is on other than the initial date of "observation status." To report services to a patient designated as "observation status" or "inpatient status" and discharged on the same date, use the codes for Observation or Inpatient Care Services [including Admission and Discharge Services, 99234-99236 as appropriate.])
99220
Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission to "observation status" are of high severity. Typically, 70 minutes are spent at the bedside and on the patient's hospital floor or unit.
99223
Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of high severity. Typically, 70 minutes are spent at the bedside and on the patient's hospital floor or unit.
99232
Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is responding inadequately to therapy or has developed a minor complication. Typically, 25 minutes are spent at the bedside and on the patient's hospital floor or unit.
99233
Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is unstable or has developed a significant complication or a significant new problem. Typically, 35 minutes are spent at the bedside and on the patient's hospital floor or unit.
99239
Hospital discharge day management; more than 30 minutes
99306
Initial nursing facility care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of high severity. Typically, 45 minutes are spent at the bedside and on the patient's facility floor or unit.
99308
Subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is responding inadequately to therapy or has developed a minor complication. Typically, 15 minutes are spent at the bedside and on the patient's facility floor or unit.
99309
Subsequent nursing facility care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient has developed a significant complication or a significant new problem. Typically, 25 minutes are spent at the bedside and on the patient's facility floor or unit.
99316
Nursing facility discharge day management; more than 30 minutes
G0008
Administration of influenza virus vaccine
G0438
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit
J3420
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

NPI
Doctor Name
Specialty
Count
1194783761
Diagnostic Radiology
2,771
1861454696
Hematology/Oncology
2,399
1568451508
Diagnostic Radiology
2,096
1144279035
Diagnostic Radiology
1,931
1225064009
Nephrology
1,840
1144213422
Cardiovascular Disease (Cardiology)
1,819
1225097074
General Practice
1,759
1659319648
Orthopedic Surgery
1,457
1962427195
Nephrology
1,419
1255324000
Cardiovascular Disease (Cardiology)
1,406
*These referrals represent the top 10 that Dr. Mittal has made to other doctors

Publications

Antioxidant effect of isoflavones: A randomized, double-blind, placebo controlled study in oophorectomized women. - International journal of applied & basic medical research
One of the postulated mechanism for cardioprotective potential of isoflavones is their ability to exert antioxidant action. However, various reports give conflicting results in this area.The present study was conducted with an objective to probe into the cardioprotective mechanism of isoflavones by evaluating their antioxidant potential in oophorectomized women.This was a randomized, double-blind, parallel, placebo controlled study. A total of 43 women were randomized to receive 75 mg/day isoflavones tablet or placebo for 12 weeks. Red blood cell antioxidant parameters including lipid peroxidation, superoxide dismutase (SOD), catalase and glutathione peroxidase (GSH-Px) were determined at baseline and at the end of the study.After 12 weeks of administration of isoflavones, there was no statistically significant difference in lipid peroxidation (P value for isoflavones: 0.37; for placebo: 0.37), catalase (P value for isoflavones: 0.35; for placebo: 0.84), SOD (P value for isoflavones: 0.41; for placebo: 0.28) and GSH-Px (P value for isoflavones: 0.92; for placebo: 0.29). There was no statistically significant difference in the proportion of patients experiencing adverse events in the two groups (P -1.00).The study strengthens the concept that the cardioprotective mechanism of isoflavones might be due to some other reason apart from the antioxidant pathway.
Foundation programme: A student's perspective. - International journal of applied & basic medical research
Various colleges and universities worldwide develop and implement students' orientation programs to acclimatize them to the campus environment, familiarize them with the teaching programs and its importance has been stressed in the document "Vision 2015" planned by the Medical Council of India (MCI).To evaluate the feedback questionnaire after conclusion of two day :Foundation Program" for MBBS 2nd Professional students, conducted by the medical education unit at a tertiary care Medical Institute.After the conclusion of two day "Foundation Program", a pre-designed, anonymous questionnaire was received from all the students who participated in the program.Of the 100 participants, 67% of the participants labeled the foundation program a very good exercise. Students' view regarding the factors that facilitated their learning were good topics (covered important aspects pertaining to the clinical phases), good presentations, good and experienced speakers, and interactive faculty.Such orientation programs lay a strong foundation for better understanding and learning of under-graduate courses, and should be a regular feature in the curriculum.
Treatment failure with disease-modifying antirheumatic drugs in rheumatoid arthritis patients. - Singapore medical journal
Rheumatoid arthritis (RA) patients taking disease-modifying antirheumatic drugs (DMARDs) may experience treatment failure due to adverse effects or a lack of efficacy/resistance. The purpose of this study was to evaluate the prescription patterns, the incidence and reasons for failure, and the time to treatment failure of DMARDs in RA patients.The medical records of patients visiting the Rheumatology Clinic were scrutinised retrospectively in order to extract the relevant data, including demographics, clinical and laboratory investigations and drug usage, for analysis.More than 60% of the 474 eligible patients were started on a combination of DMARDs. Hydroxychloroquine (HCQ) (79.7%) and methotrexate (MTX) (55.6%) were the most common DMARDs prescribed initially. There was a significant difference in survival times among the various treatment groups (p ≤ 0.001). Adverse effect was the main reason for treatment failure of sulfasalazine (SSZ) (88.9%) and MTX (75%), while addition or substitution DMARDs was more common for those taking HCQ (72.2%). Adverse event was reported as the most significant predictor of treatment failure. The most commonly reported adverse effects were bone marrow suppression and hepatotoxicity.A combination of DMARDs was used to initiate therapy in more than 60% of RA patients, with HCQ and MTX being prescribed most frequently. Adverse effects accounted mainly for treatment failures with MTX and SSZ, while lack of efficacy was responsible for major treatment failures with HCQ.
Assessment of psychological effects of dental treatment on children. - Contemporary clinical dentistry
The aim of present study is to investigate the various psychological effects on children due to dental treatment.One hundred and eighty school going children, age range between six and twelve years, were recruited into the study and divided into two groups (Group I included six to nine-year-olds and Group II included nine-to-twelve year olds). Only those children were included who underwent a certain dental treatment seven days prior to the investigation. Each child was asked a preformed set of questions. The child was allowed to explain and answer in his own way, rather than only in yes or no. The answers were recorded. After interviewing, the child was asked either to draw a picture or to write an essay related to his experience regarding the dentist and dental treatment.A majority of the children (92.22%) had a positive perception. The number of children having negative and neutral perceptions was comparatively much less. Younger children (Group I) had a more negative experience than the older children (Group II). Only one-fourth of the children complained of some pretreatment fear (23.83%); 72.09% of the children did not have any pain during dental treatment and a majority of children (80.23%) remembered their dental treatment.A majority of children had a positive perception of their dental treatment and the children in the younger age group had more negative perceptions than the children in the older age group.
Medical management of pheochromocytoma: Role of the endocrinologist. - Indian journal of endocrinology and metabolism
Pheochromocytoma is a rare tumor arising from chromaffin cells in adrenal medulla or other paraganglia in the body, which may be associated with many genetic syndromes and mutation. The role of endocrinologist is in biochemical diagnosis of suspected cases; its anatomic and functional localization with the help of imaging like CT, MRI, and nuclear scanning; preoperative control of hypertension; and postoperative follow-up of cases that have undergone surgical resection. Familial and genetic screening of cases and their family is important to detect occult cases. Endocrinologist will also play a role in cases with malignant pheochromocytoma in assessment of metastasis, control, chemoradiotherapy, and follow-up.
An unusual case of amoebic liver abscess presenting with hepatic encephalopathy: a case report. - The Malaysian journal of medical sciences : MJMS
Amoebic liver abscess (ALA) with jaundice and encephalopathy is a rare occurrence and has been recognised and studied more frequently in recent years. We present a case of massive ALA presenting with jaundice, hepatic encephalopathy, and septicaemia that was treated successfully with percutaneous drainage of the abscess, right-sided chest tube insertion, and anti-amoebic therapy.
Three cases of amoebic liver abscess causing inferior vena cava obstruction, with a review of the literature. - The Korean journal of hepatology
Amoebic liver abscess is a common disease, especially in endemic areas, but it is a rare cause of inferior vena cava (IVC) obstruction, with only a few cases appearing in the literature. We report three cases of amoebic liver abscess complicated with obstruction of the IVC and which responded to conservative treatment or radiological intervention.
Causes of DMARD withdrawal following ADR within 6 months of initiation among Indian rheumatoid arthritis patients. - Rheumatology international
The present study was conducted in Indian rheumatoid arthritis (RA) patients prescribed disease-modifying anti-rheumatic drugs (DMARDs) to determine the incidence and type of adverse drug reactions (ADRs) leading to their withdrawal in the initial 6 months of therapy. This was considered important as pharmacogenetic variations in the pattern of RA in different populations and genetic differences in efficacy and safety to drugs demand separate studies to be conducted in different populations. Hospital records were used to identify 1,000 consecutive patients with RA fulfilling the American College of Rheumatology criteria and having at least 6-month follow-up. Age, gender, duration of arthritis, drug usage and ADR-related drug withdrawal were recorded from the charts. Most of the patients were put on single DMARD. Combined use of DMARD was less frequent and non-use of DMARD was common; however, disease control was good. The commonest DMARD used in our hospital was hydroxychloroquine 444 (44%) and the commonest combination used was methotrexate with hydroxychloroquine by 55 (6%). Sulphasalazine use showed preference to young and males. Supportive drugs used were NSAIDs by 883 (88%), corticosteroids by 646 (65%), paracetamol by 594 (59%) and amitriptyline by 88 (9%). Incidence of ADR-related DMARD withdrawal was maximum with leflunomide 2/15 (13.33%) followed by methotrexate 9/116 (7.76%), sulphasalazine 6/185 (3.24%), chloroquine 3/131 (2.29%) and hydroxychloroquine 8/444 (1.8%). Severity and symptomatology of disease, genetic pattern of patients, financial status, previous experience of the clinicians and patients, availability of drugs, patient expectations and compliance were the main factors that lead to a difference in pattern of therapy in our patients compared to other population.
Secondary acute myeloid leukemia after successful treatment for osteosarcoma. - Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology
Secondary acute myeloid leukemia (sAML) is a rare complication following chemotherapy for osteogenic sarcoma. However, the exact offending drug is difficult to prove as there is no consistent data. It usually develops 2 years after completion of therapy. We report a case of sAML that developed within 8 months of completing the treatment. The patient was treated with cisplatin, doxorubicin and high-dose methotreaxate followed by surgery (amputation). Eight months after completion of therapy, while on follow-up, he presented with leukocytosis and thrombocytopenia and confirmed to have AML.
Outcome of children with Hodgkin's disease. A 10-year experience from a single institution in Kuwait. - Saudi medical journal
To evaluate the outcome of children with Hodgkin's disease over a period of 10-years from a single institution in Kuwait.Sixty-three children with previously untreated Hodgkin's disease, who were diagnosed at the Pediatric Oncology Unit of Kuwait Cancer Control Centre, Shuwaikh, Kuwait from January 1998 to December 2007 were included in the study. All cases were proved by histopathology, and staging was carried out according to the Ann Arbor system.Our series included 37 (59%) males and 26 (41%) females with a median age of 10 years (range 3-15 years). B symptoms were present in 20 (32%) children. Bulky disease was noted in 28 (44%) children, with stages III in 8 (13%) and IV in 12 (19%) children. Chemotherapy was administered as a primary treatment in 63 children. The median number of chemotherapy cycles given was 6 (range 2-8). Radiotherapy was used in 40 (63%) children. Grade III hematological toxicity was observed in 23 (37%) and grade IV in 14 (22%) children. Hypothyroidism was observed in 20 (32%) children. Fifty-five children achieved a complete remission (87%) and 2 children achieved a partial remission (3%) with an overall response rate of 90%. Three children achieved a progressive disease (5%) and response could not be evaluated in 3 (5%) children. At a median follow-up of 67 months (5.5 years), the overall survival was 91%.With moderate toxicity, combined modality therapy is effective in the treatment of childhood Hodgkin's disease.

Map & Directions

5880 49Th St N Suite N105 St Petersburg, FL 33709
View Directions In Google Maps

Nearby Doctors

6000 49Th St N
St Petersburg, FL 33709
727 215-5510
5880 49Th St N Suite 104
St Petersburg, FL 33709
727 219-9552
6000 49Th St N
St Petersburg, FL 33709
727 214-4411
6000 49Th St N
St Petersburg, FL 33709
727 215-5411
5637 49Th St N
St Petersburg, FL 33709
727 845-5540
5000 Park St N Suite 1017
St Petersburg, FL 33709
727 446-6569
6000 49Th St N Emergency Department
St Petersburg, FL 33709
727 215-5130
5800 49Th St N S-109
St Petersburg, FL 33709
727 221-1115
5880 49Th St N Suite N-104
St Petersburg, FL 33709
727 286-6100
6000 49Th St N
St Petersburg, FL 33709
727 214-4411